Coronary Artery Disease
📧 Sign up to get email alerts when something new happens for Coronary Artery Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus [NA]
A completed clinical trial evaluating GLP-1 receptor agonists on arterial stiffness, endothelial glycocalyx, and coronary flow reserve in pa…
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: MUscle Side-Effects of Atorvastatin in Coronary Patients (MUSE) -Follow-up Study [Phase 4]
Follow-up Phase 4 trial updating on muscle side-effects of atorvastatin in coronary patients.
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Balloon Pump Assisted Coronary Intervention Study [NA]
The Balloon Pump Assisted Coronary Intervention Study has completed, and its results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Angiography Study of BioNIR Drug Eluting Stent System (NIREUS) [Phase 2]
Phase 2 trial update for the BioNIR Drug Eluting Stent System (NIREUS) in coronary artery stenosis has completed.
-
FDA approval · 2021-02-17FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Brilinta (ticagrelor) submitted by AstraZeneca Pharmaceuticals LP.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: XIENCE 28 Global Study [NA]
Clinical trial update for the XIENCE 28 Global Study is completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) [Phase 3]
Phase 3 clinical trial update for the SYNERGY 48 mm stent system in coronary artery disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI [Phase 4]
Phase 4 trial comparing low maintenance dose ticagrelor versus clopidogrel in patients with type 2 diabetes undergoing PCI; results complete…
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study) [Phase 3]
Phase 3 clinical trial update investigating the impact of intensive lipid-lowering therapy on fractional flow reserve by CT (FFRCT) in coron…
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Myocardial Infarction, COmbined-device, Recovery Enhancement Study [NA]
Clinical trial update for a combined-device recovery enhancement study in acute myocardial infarction with completed status and results post…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Prasugrel 5 mg vs. Ticagrelor 60 mg in CHIP (E5TION) [Phase 4]
Phase 4 trial comparing prasugrel 5 mg versus ticagrelor 60 mg in patients with coronary artery disease; status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients [NA]
Clinical trial update on ST monitoring for detecting acute coronary syndrome events in patients with implantable cardioverter-defibrillators…
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: Low Dose One-Day Tc99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera For Detection of Coronary Disease [NA]
A completed clinical trial evaluating a low-dose one-day Technetium-99m protocol with a high-efficiency cardiac gamma camera for detecting c…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography [NA]
Completed clinical trial evaluating fractional flow reserve derived from anatomic CT angiography for coronary artery disease.
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: Second-generation Drug-eluting Stents in Diabetes [Phase 4]
Phase 4 trial update on second-generation drug-eluting stents in patients with coronary artery disease and diabetes mellitus.
-
FDA approval · 2021-01-15FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for atorvastatin calcium (generic atorvastatin) manufactured by Mylan Pharmaceuticals Inc.
-
FDA approval · 2020-12-15FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for the fixed-dose combination of amlodipine besylate and atorvastatin calcium, manufactured by …
-
FDA approval · 2020-12-11FDA Approved: AGGRASTAT — Supplemental Application (Medicure International Inc)
The FDA approved a supplemental application for AGGRASTAT (tirofiban) submitted by Medicure International Inc.
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions
Post-market registry update for the CorPath 200 system in percutaneous coronary interventions; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes [Phase 3]
Phase 3 multicenter trial investigating allopurinol to prevent kidney function loss in type 1 diabetes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: Treatment of Patients With Atherosclerotic Disease With Methotrexate-associated to LDL Like Nanoparticles [Phase 2, Phase 3]
Clinical trial update on methotrexate-associated LDL-like nanoparticles for atherosclerotic disease, covering Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2020-10-27Clinical Trial Update: Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention [Phase 4]
Phase 4 trial update evaluating topical nitroglycerine to prevent radial artery spasm, with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-27Clinical Trial Update: Treatment of Patients With Atherosclerotic Disease With Paclitaxel-associated to LDL Like Nanoparticles [Phase 2, Phase 3]
Phase 2/Phase 3 trial updating treatment of atherosclerotic disease using paclitaxel-associated LDL-like nanoparticles; status currently unk…
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: SCRIPPS V: Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting Stents [Phase 4]
Phase 4 trial update on intracoronary brachytherapy for recurrent restenosis after multiple drug-eluting stents in coronary artery disease.
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside) [Phase 4]
Phase 4 clinical trial evaluating antiplatelet therapies with the Endeavor stent for intermediate duration in coronary artery disease; compl…